Universal Health Services

UHS

Market cap $12.9B

UHS' Q4 EPS misses estimates despite a 19.5% jump, as softer admissions and rising costs weighed on results even as revenues climbed 9.1%.

Universal Health Services, Inc. (UHS) Q4 2025 Earnings Call Transcript

The headline numbers for Universal Health Services (UHS) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Universal Health Services (UHS) came out with quarterly earnings of $5.88 per share, missing the Zacks Consensus Estimate of $5.92 per share. This compares to earnings of $4.92 per share a year ago.

Hospital operator Universal Health Services on Wednesday missed estimates for quarterly results, hurt by lower-than-expected admissions.

Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended December 31, 2025 and 2024: KING OF PRUSSIA, Pa., Feb. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $445.9 million, or $7.06 per diluted share, during the fourth quarter of 2025, as compared to $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024.

UHS heads into Q4 earnings with strong Acute Care and Behavioral growth, but rising labor and supply costs could cloud a potential beat.

Get a deeper insight into the potential performance of Universal Health Services (UHS) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Universal Health Services demonstrates robust Q3 performance, with strong revenue growth, margin expansion, and disciplined capital allocation. UHS's future returns hinge on operational execution, EPS growth, and buybacks, as the stock now trades at fair value with limited multiple expansion. Management raised full-year guidance, reflecting confidence in stable volumes, declining labor costs, and incremental Medicaid reimbursements.